NGF and early-onset autosomal dominant Alzheimer disease: Currently one of these small-molecule NGF mimetics, the P75NTR binding molecule LM11A-31, is under evaluation in clinical trials in Alzheimer’s disease (Yang et al., 2008, 2020).